National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies

Page 16 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.

• A/H5N1 Vaccine in Healthy Children Aged 2-9 YearsCompletedNCT00133536Phase 1/2
• FLU-VACS Comparative Study in AdultsCompletedNCT00133523Phase 4
• Influenza Vaccine in Pediatric Transplant SubjectsCompletedNCT00133510Phase 4
• gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent FemalesCompletedNCT00133497Phase 2
• UMD rPA Regimen Trial in AdultsTerminatedNCT00133484Phase 2
• Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory AdultsCompletedNCT00133471Phase 1/2
• RCT ALB for SA CysticercosisWithdrawnNCT00133458Phase 3
• Pentavalent DTaP-Hep B-IPVCompletedNCT00133445Phase 2
• Zinc and Pneumonia ProtocolTerminatedNCT00133432Phase 3
• Micronutrients and Enteric Infections in African ChildrenCompletedNCT00133419Phase 2
• Pentoxifylline in Children With MalariaTerminatedNCT00133393Phase 2
• Comparing Allergenic Effects of 3 German Cockroach Extracts in AdultsTerminatedNCT00132847
• Methods of Determining Asthma Severity in ChildrenCompletedNCT00132834
• Analysis of Lyme Disease LesionsCompletedNCT00132327
• Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected WomenCompletedNCT00125983Phase 2
• HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult ParticipantsCompletedNCT00125970Phase 2
• CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in MalawiCompletedNCT00125489Phase 4
• Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV InfectionCompletedNCT00125099Phase 1/2
• Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected AdultsCompletedNCT00124007Phase 1
• Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African AdultsCompletedNCT00123968Phase 1/2
• Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in HaitiCompletedNCT00120510Not applicable
• Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their BabiesCompletedNCT00120471Phase 1
• Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected AdultsCompletedNCT00119873Phase 1
• Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy AdultsCompletedNCT00118924Phase 1
• A/H5N1in Adult - AventisCompletedNCT00115986Phase 1/2
• Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected AdultsCompletedNCT00115960Phase 1
• Eldery High Dose TIV 2005CompletedNCT00115531Phase 2
• Urban Environmental Factors and Childhood AsthmaCompletedNCT00114881
• Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in AdolescentsCompletedNCT00114413Not applicable
• Experimental Vaccine for MalariaCompletedNCT00114010Phase 1
• Safety and Acceptability of a Vaginal MicrobicideCompletedNCT00111943Phase 2
• Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected AdultsCompletedNCT00111605Phase 1
• Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex InfectionCompletedNCT00111397Phase 1
• Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected AdultsCompletedNCT00110578Phase 1
• Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)CompletedNCT00110279Phase 1
• "Prime-Boost" Vaccine Schedule for Prevention of HIV InfectionCompletedNCT00109629Phase 1
• Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug TherapyCompletedNCT00109603Not applicable
• Vaccine Treatment for HIV-InfectionCompletedNCT00108654Phase 1
• A Study of Anal Cancer Development in HIV Infected PeopleCompletedNCT00107679
• Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable TherapyCompletedNCT00107549Phase 1
• Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDSCompletedNCT00106795
• Vaccine to Prevent West Nile Virus DiseaseCompletedNCT00106769Phase 1
• Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral TreatmentCompletedNCT00105417Phase 1
• Computer-Generated Vs. Standard Informed Consent for HIV Research StudiesStatus unknownNCT00104559Not applicable
• An Observational Study of People Who Have Recently Been Infected With HIVCompletedNCT00103961
• Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and WomenCompletedNCT00102986Not applicable
• Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant VirusStatus unknownNCT00102934Not applicable
• Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral DensityStatus unknownNCT00102908Phase 2
• Clinical and Immunological Evaluation of Children With AllergiesCompletedNCT00102570
• A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior TherapyCompletedNCT00102206Phase 2
• HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult VolunteersCompletedNCT00102089Phase 1
• Anti-CD20 Antibody Therapy for Sjogren's SyndromeCompletedNCT00101829Phase 1
• Effect of Leflunomide on T Cell Proliferation in HIV-Infected PatientsCompletedNCT00101374Phase 1
• Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected PeopleCompletedNCT00100633Phase 1/2
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, ChinaCompletedNCT00100594Not applicable
• Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected AdultsCompletedNCT00100581Not applicable
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in SenegalCompletedNCT00100568Not applicable
• Fluarix Immunogenicity and Safety TrialCompletedNCT00100399Phase 3
• Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) TrialCompletedNCT00100386Not applicable
• RSV Challenge in Healthy AdultsCompletedNCT00100373Not applicable
• Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected AdultsCompletedNCT00099684Not applicable
• Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV DrugsCompletedNCT00099671Phase 1
• Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected PeopleCompletedNCT00099645Phase 1/2
• Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)CompletedNCT00099463Phase 1
• Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected MothersCompletedNCT00098163Phase 1
• Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected AdultsCompletedNCT00096850Not applicable
• Collection of Blood Samples From HIV Infected PeopleCompletedNCT00096772
• Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected WomenCompletedNCT00096694Not applicable
• Treating Multiple Sclerosis With Sirolimus, an Immune System SuppressorTerminatedNCT00095329Phase 1/2
• Caspofungin Study for Fungal Infections in Adults in Critical Care SettingsTerminatedNCT00095316Phase 3
• Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy AdultsCompletedNCT00094718Phase 1
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy AdultsCompletedNCT00094705Phase 1
• Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)CompletedNCT00094380Phase 1/2
• HIV Assessment in Fuyang, Anhui Province, ChinaCompletedNCT00094354
• Use of Busulfan as Conditioning Agent for a Second Stem Cell TransplantCompletedNCT00092937Phase 1
• Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited SettingsCompletedNCT00091936Not applicable
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and AdolescentsCompletedNCT00091702Phase 1/2
• Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052CompletedNCT00091416Phase 1
• Genetic Risk Factors for Severe AsthmaCompletedNCT00090740
• Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%TerminatedNCT00090194Phase 2
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy AdultsCompletedNCT00089908Phase 1
• Candidate HIV VaccineCompletedNCT00089531Phase 1
• Optimal Treatment for Kidney Disease in HIV Infected AdultsWithdrawnNCT00089518Phase 3
• Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected PatientsCompletedNCT00089466Phase 1/2
• Blood Levels of Abacavir in HIV Infected AdolescentsCompletedNCT00087945Not applicable
• Three Month Course of Anti-HIV Medications for People Recently Infected With HIVWithdrawnNCT00087464Not applicable
• Collection of Specimens for Study of Inflammatory Bowel DiseaseCompletedNCT00086554
• Long-term Follow-up of HIV Infected Patients Identified During Early InfectionCompletedNCT00086372
• Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIVCompletedNCT00086359Phase 3
• Omalizumab to Treat Eosinophilic GastroenteritisCompletedNCT00084097Phase 2
• Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIVCompletedNCT00084058Phase 1/2
• Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV TransmissionCompletedNCT00084045Not applicable
• Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIVWithdrawnNCT00084032Not applicable
• Atazanavir/Ritonavir Maintenance TherapyCompletedNCT00084019Not applicable
• Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected AdultsCompletedNCT00083603Phase 1
• Safety and Immunogenicity of an HIV Vaccine in Normal Adult VolunteersCompletedNCT00083330Phase 1
• Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected PatientsCompletedNCT00082498Phase 2
• Combination Study With MVA BN and DryvaxCompletedNCT00082446Phase 1
• Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in IndiaCompletedNCT00081640Phase 1
• Strategies for Delivering Anti-HIV Therapy in South AfricaCompletedNCT00080522Not applicable

← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas